| Application: | Internal Medicine |
|---|---|
| Usage Mode: | Intravenous |
| Suitable for: | Elderly, Children, Adult |
| State: | Liquid |
| Shape: | Liquid |
| Type: | Biological Products |
| Customization: |
|---|
Suppliers with verified business licenses
Audited Supplier Metronidazole Injection is indicated in the treatment of serious infections caused by susceptible anaerobic bacteria. Indicated su rgical procedures should be performed in conjunction with Metronidazole Injection therapy. In a mixed aerobic and anaerobic infection, antibiotics appropriate for the treatment of the aerobic infection should be used in addition to Metronidazole Injection .
Metronidazole Injection is e ffective in Bacte roides fragilis infections resistant to clindamycin, chloramphenicol, and penicillin.
Intra-Abdominal Infections, including peritonitis, intra-abdominal abscess, and liver abscess, caused by Bacte roides species including the B. fragilis group (B. fragilis, B. distasonis, B. ovatus, B. thetaiotaomic ron, B. vulgatus), Clostridium species, Eubacterium species, Peptococcus species, and Peptost reptococcus species.
Skin and Skin Structure Infections caused by Bacte roides species including the B. fragilis group, Clostridium species, Peptococcus species, Peptost reptococcus species, and Fusobacterium species.
Gynecologic Infections, including endometritis, endomyometritis, tubo-ovarian abscess, and post-su rgical vaginal cu ff infection, caused by Bacteroides species including the B. fragilis group, Clostridiumspecies, Peptococcus species, and Peptost reptococcus species.
Bacterial Septicemia caused by Bacte roides species including the B. fragilis group and Clostridiumspecies.
Bone and Joint Infections, as adjunctive therap y, caused by Bacte roides species including the B. fragilisgroup.
Central Nervous System (CNS) Infections, including meningitis and brain abscess, caused by Bacte roidesspecies including the B. fragilis group.
Lower Respiratory Tract Infections, including pneumonia, empyema, and lung abscess, caused by Bacte roides species including the B. fragilis group.
Endocarditis caused by Bacte roides species including the B. fragilis group.
Shijiazhuang No. 4 Pharmaceutical Co., Ltd., as one of the leading manufacturers in Chinese pharmaceutical industry and a well-known brand, has a business history of seventy years. The company principally specializes in R & D, manufacture and sales of wide types of drugs mainly including intravenous infusion.
The production lines have achieved full automation control and information control in the production process and logistics process and reached international advanced level by integrating the world's leading equipment and technology.
With product quality as its life, the Company always organizes production in strict accordance with GMP requirements, establishes and implements superior service concepts and measures and provides guarantee for the health of the majority of patients at home and abroad with excellent quality products and services.
The Company has a powerful R&D team and made a number of achievements in scientific research and undertaken many major scientific and technological innovation projects and industrialization projects by firmly grasping the pulse of pharmaceutical development, increasing new product development investment and accelerating the pace of technological innovation.
Large volume injection is the key products, tablets, capsules, small volume injection and other forms are manufactured also. Recently API has been put into production and sales. There are more than ten international advanced production lines for the large volume injection, its production scale, technology level, brand influence and economic benefit are on the forefront of domestic counterparts, and it has become one of China's top 100 pharmaceutical industry enterprises and China's top 10 chemical and pharmaceutical industry preparation export-oriented excellent enterprise brands for many consecutive years.
The products are radiated to all provinces, autonomous regions and municipalities in China and also exported to many overseas markets, including more than 80 countries in Asia, Americas, Europe, Oceania, Africa and other continents, and it has become one of the main export enterprises of infusion products.
Suppliers with verified business licenses
Audited Supplier 
){kind=link}
){kind=link}